跳转至内容
Merck
CN

272930

4-苄氧基苯酚

≥99%

别名:

4-(苯基甲氧基)苯酚, 氢醌单苄醚

登录 查看组织和合同定价。

选择尺寸


关于此项目

线性分子式:
C6H5CH2OC6H4OH
化学文摘社编号:
分子量:
200.23
EC Number:
203-083-3
UNSPSC Code:
12352100
PubChem Substance ID:
Beilstein/REAXYS Number:
1958305
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

assay

≥99%

mp

119-120 °C (lit.)

SMILES string

Oc1ccc(OCc2ccccc2)cc1

InChI

1S/C13H12O2/c14-12-6-8-13(9-7-12)15-10-11-4-2-1-3-5-11/h1-9,14H,10H2

InChI key

VYQNWZOUAUKGHI-UHFFFAOYSA-N

Gene Information

human ... TYR(7299)
rat ... Ar(24208)

正在寻找类似产品? 访问 产品对比指南

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2 - Skin Sens. 1

存储类别

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

法规信息

新产品

此项目有


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

K Urabe et al.
Seminars in cutaneous medicine and surgery, 16(1), 81-85 (1997-03-01)
The dyschromatoses are a group of disorders characterized by the presence of both hyperpigmented and hypopigmented macules, many of which are small in size and irregular in shape. There are two major forms-dyschromatosis symmetrica hereditaria (DSH) and dyschromatosis universalis hereditaria
K M AlGhamdi et al.
Journal of the European Academy of Dermatology and Venereology : JEADV, 25(7), 749-757 (2010-11-09)
If vitiligo involves most of the body, it might be easier to depigment the normal remaining skin rather than to attempt repigmentation. We reviewed the literature to date regarding available therapies for depigmenting the normal skin in vitiligo universalis. Our
L A Rheins et al.
Journal of immunology (Baltimore, Md. : 1950), 136(3), 867-876 (1986-02-01)
The epidermis on the backs or ears of DBA/2 mice treated for 7 days with a 20% concentration of monobenzyl ether of hydroquinone (MBEH) had a significantly greater population density of ATPase- and Ia-positive cells compared with control mice treated
Torello Lotti et al.
Dermatologic clinics, 25(3), 393-400 (2007-07-31)
This article deals with new and experimental treatments that can be used to treat various forms of depigmenting disorders. Ultraviolet B-focused therapies and new surgical approaches are analyzed in this article. These therapies were mainly or only developed to treat
A Catona et al.
The Medical journal of Australia, 146(6), 320-321 (1987-03-16)
Three cases of cutaneous depigmentation after the application of Superfade are presented. Almost total depigmentation occurred on the dorsum of the hands with spread of confetti-like depigmentation to the arms. More distant spread occurred in two cases. Superfade contains 1.5%

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持